Silence Therapeutics to Present at 21st Annual Needham Virtual Healthcare Conference
April 06 2022 - 6:00AM
Business Wire
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the
Company”), a leader in the discovery, development and delivery of
novel short interfering ribonucleic acid (siRNA) therapeutics for
the treatment of diseases with significant unmet medical need,
today announced that the Company will present at the 21st Annual
Needham Virtual Healthcare Conference at 8:00 a.m. Eastern Time on
Thursday, April 14, 2022.
A live webcast of the presentation will be available on the
Investors section of the Silence website at
www.silence-therapeutics.com. A replay of the webcast will also be
archived on the Company’s website following the conference.
About Silence Therapeutics Silence Therapeutics is
developing a new generation of medicines by harnessing the body's
natural mechanism of RNA interference, or RNAi, to inhibit the
expression of specific target genes thought to play a role in the
pathology of diseases with significant unmet need. Silence's
proprietary mRNAi GOLD™ platform can be used to create siRNAs
(short interfering RNAs) that precisely target and silence
disease-associated genes in the liver, which represents a
substantial opportunity. Silence's wholly owned product candidates
include SLN360 designed to address the high and prevalent unmet
medical need in reducing cardiovascular risk in people born with
high levels of lipoprotein(a) and SLN124 designed to address rare
hematological diseases. Silence also maintains ongoing research and
development collaborations with AstraZeneca, Mallinckrodt
Pharmaceuticals, and Hansoh Pharma, among others. For more
information, please visit
https://www.silence-therapeutics.com/.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220406005200/en/
Silence Therapeutics plc Gem Hopkins, Head of IR and
Corporate Communications ir@silence-therapeutics.com Tel: +1 (646)
637-3208
Spectralink (NASDAQ:SLNK)
Historical Stock Chart
From Oct 2024 to Oct 2024
Spectralink (NASDAQ:SLNK)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Spectralink Corp (MM) (NASDAQ): 0 recent articles
More Spectralink Corp (MM) News Articles